How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of image-guided transperineal laser ablation (TPLA) for treating lower urinary tract symptoms caused by benign prostatic hyperplasia

    Closed for comments This consultation ended on at   Request commenting lead permission

    References

    1. Bertolo R, Iacovelli V, Cipriani C et al. (2023) Ejaculatory function following transperineal laser ablation vs TURP for benign prostatic obstruction: a randomized trial. BJU Int.132(1):100-108. doi: 10.1111/bju.16008.

    2. Tafuri A, Panunzio A, De Carlo F et al. (2023) Transperineal Laser Ablation for Benign Prostatic Enlargement: A Systematic Review and Pooled Analysis of Pilot Studies. J Clin Med.12(5):1860.  doi: 10.3390/jcm12051860.

    3. Tzelves L, Nagasubramanian S, Pinitas A et al. (2023) Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature. Ther Adv Urol. 15:17562872231198634. doi: 10.1177/17562872231198634.

    4. Minafra P, De Rienzo G, Gerbasi S et al. (2023) Three years outcomes of transperineal laser ablation of the prostate. Minerva Urol Nephrol, 75 (4), 471-8

    5. Canat HL, Gurbuz C, Bozkurt M. (2023) Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study. Int Urol Nephrol. 55(11):2747-2752.

    6. Destefanis P, Sibona M, Vitiello F et al. (2023) Trans - Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction. Prostate Cancer Prostatic Dis. doi: 10.1038/s41391-023-00736-5. Epub ahead of print. PMID: 37853099.

    7. van Kollenburg R, van Riel L, Bloemen P et al. (2024) Transperineal laser ablation as treatment for benign prostatic obstruction: Safety, feasibility and functional outcomes-A pilot study. BJUI Compass. 5(1):52-59. doi: 10.1002/bco2.278.

    8. Polverino P, Lo Re M, Saladino M et al. (2023) Could transperineal interstitial laser ablation of the prostate be the right option for highly-comorbid patients with lower urinary tract symptoms due to benign prostatic obstruction? A preliminary single-center experience focusing on functional and safety outcomes. Minerva Urol Nephrol. doi: 10.23736/S2724-6051.23.05479-4. Epub ahead of print. PMID: 38093618.

    9. Bianco, Fernando J. Jr.; Luna, Eusebio; Lopez-Prieto, Alberto; González, Pedro; Gheiler, Edward L.; Kaufman, Ariel M.; Avila, Luis; Maiolino, Giuseppe. Office-Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia Under Local Anesthesia: 2-Year Results from a Dose Range Confirmatory Trial. JU Open Plus 2(2):e00007, February 2024. | DOI: 10.1097/JU9.0000000000000105